Jong-Hyuk Lee

Dr. Jong-Hyuk Lee

Biomedical Sciences, School of Medicine, Mercer University, Savannah, Georgia, USA
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2020 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
JLJong-Hyuk Lee
Jong-Hyuk Lee
EKEdward W. Kim
Edward W. Kim
DCDeborah L. Croteau
Deborah L. Croteau
VBVilhelm A. Bohr
Vilhelm A. Bohr
Aging is an inevitable process of life. Defined by progressive physiological and functional loss of tissues and organs, aging increases the risk of mortality for the organism. The aging process is affected by various factors, including genetic and epigenetic ones. Here, we review the chromatin-specific epigenetic changes that occur during normal (chronological) aging and in premature aging diseases. Taking advantage of the reversible nature of epigenetic modifications, we will also discuss possible lifespan expansion strategies through epigenetic modulation, which was considered irreversible until recently.

27 September 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JCJinmi Choi
Jinmi Choi
Hyonchol JangHyonchol Jang
Hyonchol Jang
HKHyunsoo Kim
Hyunsoo Kim
JLJong-Hyuk Lee
Jong-Hyuk Lee
SKSeong-Tae Kim
Seong-Tae Kim
HYHong-Duk Youn
Hong-Duk Youn
Myocyte enhancer factor 2 (MEF2) is a family of transcription factors that regulates many processes, including muscle differentiation. Due to its many target genes, MEF2D requires tight regulation of transcription activity over time and by location. Epigenetic modifiers have been suggested to regulate MEF2-dependent transcription via modifications to histones and MEF2. However, the modulation of MEF2 activity by lysine methylation, an important posttranslational modification that alters the activities of transcription factors, has not been studied. We report the reversible lysine methylation of MEF2D by G9a and LSD1 as a regulatory mechanism of MEF2D activity and skeletal muscle differentiation. G9a methylates lysine-267 of MEF2D and represses its transcriptional activity, but LSD1 counteracts it. This residue is highly conserved between MEF2 members in mammals. During myogenic differentiation of C2C12 mouse skeletal muscle cells, the methylation of MEF2D by G9a decreased, on which MEF2D-dependent myogenic genes were upregulated. We have also identified lysine-267 as a methylation/demethylation site and demonstrate that the lysine methylation state of MEF2D regulates its transcriptional activity and skeletal muscle cell differentiation.

1 November 2009 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JLJong-Hyuk Lee
Jong-Hyuk Lee
Hyonchol JangHyonchol Jang
Hyonchol Jang
ECEun-Jung Cho
Eun-Jung Cho
HYHong-Duk Youn
Hong-Duk Youn

26 May 2015 in Stem Cells
Verified
Journal Article
Open access
PDF file
TKTae Wan Kim
Tae Wan Kim
BKByung-Hee Kang
Byung-Hee Kang
Hyonchol JangHyonchol Jang
Hyonchol Jang
SKSojung Kwak
Sojung Kwak
JSJihoon Shin
Jihoon Shin
HYHong-Duk Youn
Hong-Duk Youn
For cells to exit from pluripotency and commit to a lineage, the circuitry of a core transcription factor (CTF) network must be extinguished in an orderly manner through epigenetic modifications. However, how this choreographed epigenetic remodeling at active embryonic stem cell (ESC) genes occurs during differentiation is poorly understood. In this study, we demonstrate that C-terminal binding protein 2 (Ctbp2) regulates nucleosome remodeling and deacetylation (NuRD)-mediated deacetylation of H3K27 and facilitates recruitment of polycomb repressive complex 2 (PRC2)-mediated H3K27me3 in active ESC genes for exit from pluripotency during differentiation. By genomewide analysis, we found that Ctbp2 resides in active ESC genes and co-occupies regions with ESC CTFs in undifferentiated ESCs. Furthermore, ablation of Ctbp2 effects inappropriate gene silencing in ESCs by sustaining high levels of H3K27ac and impeding H3K27me3 in active ESC genes, thereby sustaining ESC maintenance during differentiation. Thus, Ctbp2 preoccupies regions in active genes with the NuRD complex in undifferentiated ESCs that are directed toward H3K27me3 by PRC2 to induce stable silencing, which is pivotal for natural lineage commitment. Stem Cells 2015;33:2442–2455

23 November 2014 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
JLJong-Hyuk Lee
Jong-Hyuk Lee
Hyonchol JangHyonchol Jang
Hyonchol Jang
SLSoon‐Min Lee
Soon‐Min Lee
JLJi‐Eun Lee
Ji‐Eun Lee
JCJinmi Choi
Jinmi Choi
HYHong-Duk Youn
Hong-Duk Youn

15 February 2016 in eLife
Verified
Journal Article
Open access
JSJihoon Shin
Jihoon Shin
TKTae Wan Kim
Tae Wan Kim
HKHyunsoo Kim
Hyunsoo Kim
HKHye Ji Kim
Hye Ji Kim
MSMin Young Suh
Min Young Suh
HYHong-Duk Youn
Hong-Duk Youn
Pluripotency transcription programs by core transcription factors (CTFs) might be reset during M/G1 transition to maintain the pluripotency of embryonic stem cells (ESCs). However, little is known about how CTFs are governed during cell cycle progression. Here, we demonstrate that the regulation of Oct4 by Aurora kinase b (Aurkb)/protein phosphatase 1 (PP1) during the cell cycle is important for resetting Oct4 to pluripotency and cell cycle genes in determining the identity of ESCs. Aurkb phosphorylates Oct4(S229) during G2/M phase, leading to the dissociation of Oct4 from chromatin, whereas PP1 binds Oct4 and dephosphorylates Oct4(S229) during M/G1 transition, which resets Oct4-driven transcription for pluripotency and the cell cycle. Aurkb phosphor-mimetic and PP1 binding-deficient mutations in Oct4 alter the cell cycle, effect the loss of pluripotency in ESCs, and decrease the efficiency of somatic cell reprogramming. Our findings provide evidence that the cell cycle is linked directly to pluripotency programs in ESCs.